By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Omnipod products2.67B98.74%
Drug Delivery34.1M1.26%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
U.S.1.95B72.15%
International754.3M27.85%